|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1700 EUR | -0.58% |
|
-2.86% | - |
| 25-09-30 | Celyad Oncology to Sell Belgian Research Facility for EUR3 Million | MT |
| 25-09-29 | Celyad Oncology announces research facility divestiture | RE |
EPS & Dividend: Celyad Oncology SA
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -2.286 | -1.234 | -1.699 | -1.812 | -0.3284 | -0.1406 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 9.7000 | 6.6200 | 3.5150 | 0.5060 | 0.3900 | 0.7120 |
| Nbr of stocks (in thousands) | 13,942 | 13,942 | 22,594 | 22,594 | 41,429 | 41,429 |
| Announcement Date | 3/25/20 | 3/24/21 | 3/24/22 | 3/23/23 | 4/4/24 | 4/4/25 |
1EUR in Million2EUR
Estimates
Upcoming events: Celyad Oncology SA
More events
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.88% | 1.01% | 38.6x | 3.98x | 5.61x | |
| - | - | - | - | - | |
| -.--% | -.--% | 33.64x | 6.41x | 3.34x | |
| -.--% | -.--% | 103.66x | 9.38x | 6.64x | |
| 0.35% | 0.36% | 54.92x | 2.63x | 11.26x | |
| -.--% | -.--% | -21.27x | 14.47x | 6171.3x | |
| - | - | - | - | - | |
| -.--% | -.--% | 40.96x | 40.89x | 6.64x | |
| - | - | - | - | - | |
| Average | 0.21% | 0.23% | 41.75x | 12.96x | 1,034.13x | |
| Weighted average by Cap. | 0.27% | 0.31% | 45.70x | 9.67x | 719.20x |
Select your edition
All financial news and data tailored to specific country editions
